Trial of Therapeutic Vaccine in Patients With Cholangiocarcinoma

Clinical trial NCT03042182 · UNKNOWN

Trial details

NCT number: NCT03042182
Sponsor: Immunitor LLC
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cholangiocarcinoma

Start date: 2017-02-20
Primary completion: 2020-02-20
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.